Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units;

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Vidal-Cortés P.
  • Díaz Santos E.
  • Aguilar Alonso E.
  • Amezaga Menéndez R.
  • Ballesteros M.Á.
  • Bodí M.A.
  • Bordejé Laguna M.L.
  • Garnacho Montero J.
  • García Sánchez M.
  • López Sánchez M.
  • Martín-Loeches I.
  • Ochagavía Calvo A.
  • Alcántara Carmona S.
  • Andaluz Ojeda D.
  • Badallo Arébalo O.
  • Barrasa González H.
  • Borges Sa M.
  • Estella Á.
  • Ferrer Roca R.
  • Fraile Gutiérrez V.
  • Fuset Cabanes M.
  • Giménez-Esparza Vich C.
  • González Iglesias C.
  • Hernández-Tejedor A.
  • Igeño Cano J.C.
  • Iglesias Posadilla D.
  • Jiménez Rivera J.J.
  • Llanos Jorge C.
  • Llompart-Pou J.A.
  • López Camps V.
  • Lorencio Cárdenas C.
  • Marcos Neira P.
  • Martín Delgado M.C.
  • Martín-Macho González M.
  • Martín Villén L.
  • Nuvials Casals X.
  • Ortiz Suñer A.
  • Quintana Díaz M.
  • Rascado Sedes P.
  • Recuerda Núñez M.
  • del Río Carbajo L.
  • Rodríguez Aguirregabiria M.
  • Rodríguez Oviedo A.
  • Seijas Betolaza I.
  • Soriano Cuesta C.
  • Suberviola Cañas B.
  • Vera Ching C.
  • Vidal González Á.
  • Zapata Fenor L.
  • Zaragoza Crespo R.

Grupos

Abstract

The COVID-19 pandemic has led to the admission of a high number of patients to the ICU, generally due to severe respiratory failure. Since the appearance of the first cases of SARS-CoV-2 infection, at the end of 2019, in China, a huge number of treatment recommendations for this entity have been published, not always supported by sufficient scientific evidence or with methodological rigor necessary. Thanks to the efforts of different groups of researchers, we currently have the results of clinical trials, and other types of studies, of higher quality. We consider it necessary to create a document that includes recommendations that collect this evidence regarding the diagnosis and treatment of COVID-19, but also aspects that other guidelines have not considered and that we consider essential in the management of critical patients with COVID-19. For this, a drafting committee has been created, made up of members of the SEMICYUC Working Groups more directly related to different specific aspects of the management of these patients. © 2021 Elsevier España, S.L.U. y SEMICYUC

Datos de la publicación

ISSN/ISSNe:
0210-5691, 1578-6749

Medicina Intensiva  ELSEVIER ESPANA SLU

Tipo:
Article
Páginas:
81-89
PubMed:
34545260
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
0,333 SCImago ℠
Cuartil:
Q2 SCImago ℠

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • COVID-19; Critical Illness; Humans; Intensive Care Units; Pandemics; SARS-CoV-2; adult; article; controlled study; COVID-19 testing; critically ill patient; human; intensive care unit; practice guideline; critical illness; intensive care unit; pandemic

Compartir